Results 51 to 60 of about 671,938 (120)
Food Frontiers, Volume 7, Issue 6, November 2026.ABSTRACT Epilepsy is the most disabling neurological disease that affects all economic classes, age groups, regions, and races. Although many antiseizure drugs are approved for epilepsy treatment, they fail to work in about 30%–40% of patients. Thus, there is a great need to identify better pharmacological agents to treat epilepsy.
Janakiraman Pillai Udaiyappan +3 more
wiley +1 more source
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Autism Spectrum Disorder
Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.A case series studying outcomes up to 18 months in autistic patients from the UK Medical Cannabis Registry. ABSTRACT Introduction Autism spectrum disorder (ASD) is a neurodevelopmental disorder associated with distressed behaviors and psychological challenges.
Arushika Aggarwal +17 more
wiley +1 more source
Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 3, September 2026.ABSTRACT Background Psychotropics are increasingly prescribed in paediatrics despite limited evidence regarding their benefits and effectiveness. Although deprescribing approaches are established in adults, structured paediatric strategies remain poorly defined.
Paul‐Benoît Fargier +6 more
wiley +1 more source
Acute-onset amnesia: transient global amnesia and other causes [PDF]
, 2022 Acute-onset amnesia is a dramatic neurological presentation that can cause considerable concern to both patient and clinician. The patient typically presents with an inability to not only retain new memories but also access previously acquired ...
Miller, Thomas, Butler, Christopher
core +1 more source
Brain and Behavior, Volume 16, Issue 8, August 2026.This umbrella review of 29 meta‐analyses found that HF‐rTMS significantly improves cognition in Alzheimer's disease and vascular cognitive impairment. However, GRADE shows that most evidence is of low‐to‐very‐low certainty, and AMSTAR‐2 rates over 60% of reviews as critically low quality. Well‐designed trials are urgently needed.
Lin‐ling Wu +3 more
wiley +1 more source
Persistent Bilateral [18F]THK5351 and Migrating Unilateral [18F]FDG Uptake in Anti‐LGI1 Encephalitis
Annals of Clinical and Translational Neurology, Volume 13, Issue 7, Page 1512-1517, July 2026.ABSTRACT Anti–leucine‐rich glioma‐inactivated 1 encephalitis (LGI1‐E) can cause persistent cognitive deficits, but the mechanisms remain unclear. A 40‐year‐old woman with LGI1‐E presented with subacute cognitive deficits and showed mild left medial temporal lobe (MTL) swelling and fluid‐attenuated inversion recovery (FLAIR) hyperintensity on initial ...
Yusuke Akitomi +8 more
wiley +1 more source
Alzheimer's &Dementia, Volume 22, Issue 7, July 2026.Abstract INTRODUCTION Declining nicotinamide adenine dinucleotide (NAD+) may elevate risk of Alzheimer's disease. METHODS We conducted a 12‐week double‐blind, randomized, placebo‐controlled pilot study to evaluate the safety, tolerability, and preliminary efficacy of the NAD+ precursor, nicotinamide riboside (NR), for enhancing cognitive function and ...
Christopher R. Martens +16 more
wiley +1 more source
A case of transient epileptic amnesia with radiological localization.
, 2008 BACKGROUND: A 54-year-old man presented to a cognitive disorders clinic having experienced recurrent episodes of transient amnesia over a number of years.
Christopher R Butler +3 more
core +1 more source
The Rhythmic and the Metronomic: On Charlie Chaplin's Gait
Critical Quarterly, EarlyView.
Matthew Beaumont
wiley +1 more source